Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway
Ruxin Wang, Xiaofang Zhang, Haowen Ye, Xian Yang, Yongting Zhao, Liangyan Wu, Han Liu, Yun Wen, Jiaxin Wang, Ying Wang, Meixin Yu, Caixia Ma, Lihong Wang · 2024
Read Fibroblast growth factor 21 improves diabetic cardiomyopathy by inhibiting ferroptosis via ferritin pathway by Ruxin Wang, Xiaofang Zhang, Haowen Ye, Xian Yang, Yongting Zhao, Liangyan Wu, Han Liu, Yun Wen, Jiaxin Wang, Ying Wang, Meixin Yu, Caixia Ma, Lihong Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11531115.txt.
Description
BackgroundDiabetic cardiomyopathy (DCM) is a serious complication in patients with type 2 diabetes mellitus, and its mechanisms are complex and poorly understood. Despite growing evidence suggesting that ferroptosis plays a significant role in cardiovascular disease, it has been less extensively studied in DCM.
Catalog record
| CREATOR | Ruxin Wang, Xiaofang Zhang, Haowen Ye, Xian Yang, Yongting Zhao, Liangyan Wu, Han Liu, Yun Wen, Jiaxin Wang, Ying Wang, Meixin Yu, Caixia Ma, Lihong Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |